Humana IncNYSE:HUM
- LAST PRICE341.7900
- TODAY'S CHANGE (%)2.2100 (0.6508%)
- Bid / Lots341.6200/ 4
- Ask / Lots342.0700/ 4
- Open / Previous Close341.2100 / 339.5800
- Day Range
- 52 Week Range
- Volume90,200
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HUM |
|---|---|---|
| 09:32 ET | 7668 | 340.85 |
| 09:34 ET | 1000 | 341.195 |
| 09:36 ET | 4899 | 339.69 |
| 09:38 ET | 4622 | 339.67 |
| 09:39 ET | 5922 | 338.74 |
| 09:41 ET | 4396 | 339.29 |
| 09:43 ET | 3459 | 338.42 |
| 09:45 ET | 2376 | 339.3 |
| 09:48 ET | 2274 | 339.09 |
| 09:50 ET | 200 | 339.54 |
| 09:52 ET | 2737 | 339.1 |
| 09:54 ET | 860 | 338.88 |
| 09:56 ET | 1201 | 338.9 |
| 09:57 ET | 700 | 338.53 |
| 09:59 ET | 1961 | 339.275 |
| 10:01 ET | 1746 | 340.04 |
| 10:03 ET | 1564 | 340.23 |
| 10:06 ET | 1817 | 340.93 |
| 10:08 ET | 1300 | 341.48 |
| 10:10 ET | 2200 | 341.79 |
Yesterday
*DJ Humana: Jim Rechtin to Assume Humana CEO Role Effective July 1 >HUM, from 17 hours ago by Dow Jones
17 hours ago by Dow JonesJim Rechtin to Assume Humana CEO Role Effective July 1, 2024, from 17 hours ago by Dow Jones
17 hours ago by Dow Jones
May 9, 2024
AREX Capital Expresses Disappointment in Enhabit's Strategic Review Conclusion, from 9:15AM ET on Thursday May 09, 2024 by Dow Jones
9:15AM ET on Thursday May 09, 2024 by Dow Jones
May 8, 2024
DJ Correction to CVS Stock Is Dirt Cheap. That Doesn't Make It a Buy. -- Barrons.com, from 1:36PM ET on Wednesday May 08, 2024 by Dow Jones
1:36PM ET on Wednesday May 08, 2024 by Dow Jones
May 3, 2024
DJ Review & Preview: CVS: Shock And Fall -- Barron's, from 9:31PM ET on Friday May 03, 2024 by Dow Jones
9:31PM ET on Friday May 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Humana Inc | 40.9B | 21.3x | +9.96% |
Centene Corp | 41.2B | 15.3x | +17.00% |
Molina Healthcare Inc | 20.6B | 19.0x | +12.22% |
Elevance Health Inc | 125.2B | 20.4x | +12.35% |
Progyny Inc | 2.6B | 45.3x | --- |
Alignment Healthcare Inc | 1.3B | -8.4x | --- |
Company Information
Humana Inc. is a healthcare company. It operates through two segments: Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly through group Medicare accounts. It also includes its contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI-NET), a prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. It also includes products consisting of employer group commercial fully insured medical and specialty health insurance benefits. The CenterWell segment includes pharmacy solutions, primary care, and home solutions operations. It also includes its strategic partnerships with Welsh, Carson, Anderson & Stowe (WCAS) to develop and operate senior-focused, payor-agnostic, primary care centers, as well as a minority ownership interest in Gentiva Hospice operations.
Contact Information
- Headquarters
- 500 W Main StLOUISVILLE, KY, United States 40202
- Phone
- 502-580-1000
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Kurt Hilzinger
- President, Chief Operating Officer
- James Rechtin
- Chief Executive Officer, Director
- Bruce Broussard
- Chief Financial Officer
- Susan Diamond
- President - Enterprise Growth
- David Dintenfass
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $40.9B |
|---|---|
Revenue (TTM) | $109.2B |
Shares Outstanding | 120.5M |
Dividend Yield | 1.04% |
Annual Dividend Rate | 3.5400 USD |
Ex-Dividend Date | 06-28-24 |
Pay Date | 07-26-24 |
Beta | 0.51 |
EPS | $16.07 |
Book Value | $133.05 |
P/E Ratio | 21.3x |
Price/Sales (TTM) | 0.4 |
Price/Cash Flow (TTM) | 13.7x |
Operating Margin | 3.23% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
